#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Desmoplastic small round cell tumour Systemic candida Acute graft versus host disease in liver Marginal zone lymphoma refractory Raynaud's phenomenon Osteogenesis imperfecta B-cell lymphoma refractory Extra-osseous Ewing's sarcoma Bile acid synthesis disorder Still's disease Li-Fraumeni syndrome Severe myoclonic epilepsy of infancy Glomerulonephritis minimal lesion Diabetes insipidus Anti-glomerular basement membrane disease More trials…

    Learn about Rare Diseases

    CADASIL – Life with Disease X-linked lymphoproliferative syndrome – Trials in Disease Synovial sarcoma – Basic Information Nephroblastoma – Trials in Disease Rhabdomyosarcoma recurrent – Treatment Nephroblastoma Congenital hypotransferrinaemia – Diagnostics Piriformis syndrome – Basic Information Langerhans cell sarcoma – Diagnostics Testicular leiomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nanatinostat Nmd670 SAR443820 ANERATRIGINE MESILATE Elexacaftor Alx148 Tulisokibart Gandotinib Risperidone Bilastine AMO959 Formoterol Fumarate Dihydrate Gd2Il18Cart Amniotic Membrane, Human BLEXIMENIB Cefepime Hydrochloride Recombinant Interferon Beta-1B Enzalutamide Mebufotenin Rbl016.2 More therapies…

    Learn about Your Condition

    Corneal graft failure Type IIa hyperlipidaemia Nephrogenic anaemia Medulloblastoma Allergic respiratory disease Fracture infection Muscle spasticity Mixed dementia Ovarian granulosa cell tumour Rosai-Dorfman syndrome Malignant peritoneal neoplasm Prostate cancer recurrent Paedophilia Multiple system atrophy Corticobasal degeneration More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mhctoi Zzdnaoiu Khhvf 2jl Dtnujmbvw 4mbeh Hildraz

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Tolinapant Lactate
    • Cedazuridine
    • Decitabine
    France Hungary Italy Poland Spain

  • Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Carfilzomib
    • Dexamethasone
    • Mezigdomide
    Austria Bulgaria Denmark Germany Greece Hungary +5

  • Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pembrolizumab
    Austria France Germany Hungary Italy The Netherlands +4

  • Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Cisplatin
    • Fluorouracil
    Belgium Czechia Denmark Estonia France Germany +4

  • Study on Long-term Safety of Ustekinumab for Children with Crohn’s Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Ustekinumab
    Belgium France Germany Hungary Italy Poland +1

  • Study on the Effectiveness and Safety of OG-6219 and Naproxen Sodium for Women Aged 18-49 with Moderate to Severe Endometriosis Pain

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • For-6219
    • Naproxen Sodium
    Belgium Bulgaria Czechia France Germany Hungary +4

  • Study of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Austria Belgium Finland France Germany Greece +7

  • Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Croatia Czechia Estonia France +9

  • Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia Denmark Finland France +13

  • Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Cisplatin
    • Fluorouracil
    • Gemcitabine Hydrochloride
    Czechia Estonia France Hungary Italy Latvia +5
Previous Page
1 … 45 46 47 48 49 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!